Immuno-oncology and immunotherapy Part C
Autor: | Lorenzo Galluzzi, Norma Bloy, Maud Charpentier |
---|---|
EAN: | 9780443296215 |
eBook Format: | PDF/ePUB |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 15.01.2025 |
Kategorie: | |
Schlagworte: | 1N11 11.31 Acid extraction Activation markers Adoptive T cell therapy Annexin V Antibody purification Antitumor cytotoxicity Antitumor immune response BOLD BTN3A Bavituximab CAR T cells CD8 T cell CD137 CD154 Cancer Cancer immunology |
160,00 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Immuno-oncology and immunotherapy, Part C, Volume 191 in the Methods in Cell Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Extraction and quantification of histones from human cells, Expression and characterization of Phosphatidylserine-targeting antibodies for biochemical and therapeutic applications, ILC differentiation from HSCs in vitro, Methods to expand human Treg cells and assay their function, Monitoring rapid activation of human gamma/delta T cells by multicolor flow cytometry, Methods to induce T cell exhaustion in vitro, Ex vivo assessment of human neutrophil motility and migration, and much more.Additional chapters focus on Flow cytometry-based monitoring of myeloid-derived suppressor cells in the peripheral blood of patients with solid tumors, Deciphering human blood and tumor neutrophil heterogeneity: Methods for isolation and assessing suppression of T-cell proliferation, Splenocyte anticancer citotoxicity assessment after prophylactic vaccination or drug treatment of tumor-bearing mice, Therapeutic treatment of tumor-bearing mice with drug-killed cancer cells: a method to confirm immunogenic cell death and assess its therapeutic effectiveness, and much more. - Authored by established and active cell biologists and immunologist and drawn from international sources. - Includes in-depth coverage and detailed protocols. - Present a highly specialized group of topics that delve deep into new updates and future prospects.